Nature Communications · 2018 · 297 citations · 25 references
MedicineOncologyPharmacologyChemotherapyNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineHypoxia AdaptationInorganic NanoparticlesNanomedicinePhotodynamic TherapyReactive Oxygen SpeciesAnticancer ActivityCancer NanotherapyHypoxia-driven Therapy ResistanceHypoxia-induced ResistanceHypoxia-mediated ResistanceNanoparticlesPhotosensitizersUpconversion Nanoparticles
Abstract Cancer cells in hypoxic tumors are remarkably resistant to photodynamic therapy. Here, we hypothesize that an oxygen and Pt(II) self-generating multifunctional nanocomposite could reverse the hypoxia-triggered PDT resistance. The nanocomposite contains Pt(IV) and chlorin e6, in which upconversion nanoparticles are loaded to convert 980 nm near-infrared light into 365 nm and 660 nm emissions. Upon accumulation at the tumor site, a 980 nm laser is used to trigger the nanocomposite to generate O 2 for consumption in the PDT process and to produce cytotoxic reactive oxygen species. The composite also releases active Pt(II) for synergistic photo-chemo therapy to enhance antitumor efficiency. The oxygen and Pt(II) self-generating prodrug is shown to have high potential to inhibit tumors out of the range of UV light, to overcome the hypoxia-triggered PDT resistance and significantly improve anticancer efficacy by the synergistic PDT-chemotherapy.
25
Qian Chen, Liangzhu Feng, Jingjing Liu et al. · Advanced Materials · 2016 · 1K citations
Pharmacy, Oncology, Pharmaceutics +17
Huachao Chen, Jiangwei Tian, Weijiang He et al. · Journal of the American Chemical Society · 2015 · 806 citations
Pharmacy, Oncology, Pharmacology +17